Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization

Hypertension

Volumn 35, Issue 6, 2000, Pages 1314-1318

  Honing, Marina L H ^a   Smits, Paul ^b   Morrison, Paul J ^a   Rabelink, Ton J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bradykinin; Hyperpolarization; Nitric oxide; Prostaglandins; Tetraethylammonium chloride

Indexed keywords

BRADYKININ;

ARTICLE; HUMAN; HYPERPOLARIZATION; HYPERTENSION; NORMAL HUMAN; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0034119983     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.6.1314     Document Type: Article

References (29)

1. Barrow SE, Dollery CT, Heavey DJ, Hickling NE, Ritter JM, Mial J. Effect of vasoactive peptides on prostacyclin synthesis in man. Br J Pharmacol. 1986;87:243-247.
2. G-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm. Br J Clin Pharmacol. 1994;38:311-315.
3. Mombouli JV, Illiano S, Nagao T, Scott-Burden T, Vanhoutte PM. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res. 1992;71:137-144.
4. Nagao T. Illiano S, Vanhoutte PM. Heterogeneous distribution of endothelium-dependent relaxations resistant to Nc-nitro-L-arginine in rats. Am J Physiol. 1992;263:H1090-H1094.
5. Kato M, Shiode N, Yamagata T, Matsuura H, Kajiyama G. Bradykinin induced dilatation of human epicardial and resistance coronary arteries in vivo: effect of inhibition of nitric oxide synthesis. Heart. 1997;78:493-498.
6. Harasawa LU, Shimokawa H, Nakashima M, Egashira K, Takeshita A. Importance of endothelium-derived hyperpolarizing factor in human arteries. J Clin Invest. 1997;100:2793-2799.
7. Mügge A, Lopez JAG, Piegors DJ, Breese KR, Heistad DD. Acetylcholine-induced vasodilatation in rabbit hindlimb in vivo is not inhibited by analogues of L-arginine. Am J Physiol. 1991;260: H242-H247.
8. Regoli D, Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev. 1980;32:1-46.
9. Nakashima M, Mombouli JV, Taylor AA, Vanhoutte PM. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest. 1993;92:2867-2871.
10. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension. 1995;25:918-923.
11. Verhaar MC, Stachan FE, Newby DE, Cruden NL, Koomans HA, Rabelink TJ, Webb DJ. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation. 1998;97:752-756.
12. Heavey DJ, Barrow SE, Hickling NE, Ritter JM. Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man. Nature. 1985;318:186-188.
13. Langton PD, Nelson MT, Y Huang, Standen NB. Block of calcium-activated potassium channels in mammalian arterial myocytes by tetraethylammonium ions. Am J Physiol. 1991;260:H927-H934.
14. Pickkers P, Hughes AD, Russel FGM, Thien T, Smits P. Thiazide-induced vasodilation in humans is mediated by potassium channel activation. Hypertension. 1998;32:1071-1076.
15. Stroes ES, Koomans HA, de Bruin TWA, Rabelink TJ. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet. 1995;346:467-471.
16. Bruning TA, van Zwieten PA, Blauw GJ, Chang PC. No functional involvement of 5-hydroxytryptamine 1a receptors in nitric oxide dependent dilation caused by serotonin in the human forearm vascular bed. J Cardiovasc Pharmacol. 1994;24:454-561.
17. Champion HC, Kadowitz PJ. Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanism. Am J Physiol. 1997;273:R414-R422.
18. Sudhir K, Chou TM, Hutchison SJ, Chatterjee K. Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo: differential contribution of NO and bradykinin in conductance and resistance arteries. Circulation. 1996;93:1734-1739.
19. + channels. Circulation. 1999;99: 3132-3138.
20. Cockcroft JR, Chowienczyk PJ, Brett SE, Ritter JM. Effect of NG-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm. Br J Clin Pharmcol. 1994;38:307-310.
21. G-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm. Br J Clin Pharmacol. 1994;38:311-315.
22. Cowan CL, Chohen RA. Two mechanisms mediate relaxation by bradykinin of pig coronary artery: NO-dependent and -independent responses. Am J Physiol. 1991;261-H830-H835.
23. ω-nitro-L-arginine/indomethacin-resistant endothelium-dependent relaxation in porcine coronary artery. Circulation. 1995;92: 3520-3526.
24. Heygate KM, Lawrence IG, Bennett MA, Thurston H. Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats. Br J Pharmacol. 1995;116:3251-3259.
25. Weintraub NL, Joshi SN, Brauch CA, Stephenson AM, Sprague RS, Lonigro AJ. Relaxation of porcine coronary artery to bradykinin: role of arachidonic acid. Hypertension. 1994;23:976-981.
26. Urakami-Harasawa L, Shimokawa H, Nakashima M, Egashira K, Takeshita A. Importance of endothelium-derived hyperpolarizing factor in human arteries. J Clin Invest. 1997;100:2793-2799.
27. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995; 268:C799-C822.
28. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation. 1995;92:3337-3349.
29. Vanhoutte PM, Boulanger CM, Illiana SC, Nagao T, Vidai M, Mombouli JV. Endothelium-dependent effects of converting-enzyme inhibitors. J Cardiovasc Pharmacol. 1993;22:S10-S16.